Beam Therapeutics Ownership | Who Owns Beam Therapeutics?
Beam Therapeutics Ownership Summary
Beam Therapeutics is owned by 106.24% institutional investors, 1.19% insiders. Farallon capital management is the largest institutional shareholder, holding 9.82% of BEAM shares. ARK Innovation ETF is the top mutual fund, with 7.31% of its assets in Beam Therapeutics shares.
BEAM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Beam Therapeutics | 106.24% | 1.19% | -7.43% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 10.01M | 9.82% | $170.32M |
| Blackrock | 7.63M | 9.34% | $178.87M |
| Vanguard group | 7.62M | 9.25% | $189.03M |
| Ark investment management | 8.85M | 8.67% | $150.50M |
| Blackrock funding, inc. /de | 8.00M | 7.85% | $136.13M |
| Sumitomo mitsui trust | 3.96M | 4.80% | $98.15B |
| Nikko asset management americas | 4.73M | 4.63% | $80.40M |
| Arch venture management | 4.54M | 4.45% | $77.23M |
| Fmr | 3.32M | 4.03% | $82.27M |
| State street | 3.08M | 3.73% | $76.32M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mwg management | 2.27M | 74.30% | $38.56M |
| Arch venture management | 4.54M | 25.82% | $77.23M |
| Kynam capital management, lp | 2.42M | 4.43% | $41.12M |
| Redmile group | 1.42M | 2.58% | $24.21M |
| Casdin capital | 1.45M | 2.25% | $24.66M |
| Avidity partners management lp | 409.40K | 1.39% | $6.96M |
| Ark investment management | 8.85M | 1.10% | $150.50M |
| Bellevue group | 2.89M | 1.08% | $49.15M |
| Nikko asset management americas | 4.73M | 0.80% | $80.40M |
| Integral health asset management | 500.00K | 0.78% | $8.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 1.82M | 0.01% | 1.63M |
| Blackrock | 7.63M | 0.00% | 928.75K |
| Voloridge investment management | 1.13M | 0.07% | 816.36K |
| Qube research | 593.82K | 0.01% | 593.82K |
| Integral health asset management | 500.00K | 0.78% | 500.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 803.83K | 0.00% | -3.32M |
| Darwin global management | - | - | -2.12M |
| Temasek (private) | - | - | -1.81M |
| Fmr | 3.32M | 0.00% | -894.22K |
| Deerfield management company, l.p. (series c) | - | - | -877.81K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Qube research | 593.82K | 0.01% | 593.82K | $10.10M |
| Integral health asset management | 500.00K | 0.78% | 500.00K | $8.51M |
| Caption management | 348.44K | 0.07% | 348.44K | $5.93M |
| Woodline partners lp | 282.12K | 0.05% | 282.12K | $7.00M |
| Campbell & co investment adviser | 226.74K | 0.24% | 226.74K | $3.86M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -4.00 |
| Sjs investment consulting | -5.00 |
| Massmutual trust co fsb/adv | -5.00 |
| Southstate | -5.00 |
| Assetmark | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 229 | -4.98% | 108,356,461 | 8.36% | 106 | 0.82% | 117 | -17.61% | 65 | 44.44% |
| Mar 31, 2025 | 242 | 1.26% | 101,365,370 | 24.41% | 115 | 1.18% | 143 | 16.26% | 46 | -28.13% |
| Dec 31, 2024 | 237 | 3.95% | 81,473,315 | 3.08% | 98 | 1.07% | 120 | 17.65% | 65 | -1.52% |
| Sep 30, 2024 | 225 | 1.81% | 78,990,351 | 1.88% | 95 | 1.08% | 102 | -5.56% | 66 | 4.76% |
| Jun 30, 2024 | 219 | -6.01% | 77,530,743 | 10.73% | 94 | 1.15% | 107 | -21.90% | 62 | 31.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 7.39M | 7.31% | 702.37K |
| ARK Disruptive Innovation Full Composite | 6.09M | 6.02% | 336.83K |
| Fidelity Growth Compy Commingled Pl S | 3.67M | 3.65% | 35.37K |
| Vanguard Total Stock Mkt Idx Inv | 3.09M | 3.05% | -102.10K |
| Nikko AM ARK Disruptive Innovation A USD | 2.92M | 2.90% | -98.23K |
| Amova ARK Disruptive Innovation A USD | 2.88M | 2.85% | -38.26K |
| Fidelity Growth Company Fund | 2.78M | 2.77% | 23.40K |
| Vanguard US Total Market Shares ETF | 2.33M | 2.34% | 2.59K |
| Vanguard Small Cap Index | 2.32M | 2.29% | -13.15K |
| iShares Russell 2000 ETF | 2.26M | 2.23% | -42.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 30, 2025 | FMR LLC | See Remark 1 | Sell | $991.67K |
| Jul 01, 2025 | Simon Amy | Chief Medical Officer | Sell | $6.34K |
| Jul 03, 2025 | Simon Amy | Chief Medical Officer | Sell | $17.63K |
| Apr 01, 2025 | Bellon Christine | Chief Legal Officer | Sell | $104.12K |
| Apr 01, 2025 | Evans John M. | CEO | Sell | $562.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2033 Q2 | - | - |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 7 |
BEAM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools